SCHEMBL21292668

SCHEMBL21292668

Cc1cccc(C=NNC(=O)c2ccc(O)cc2O)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.67
KMT2A Q03164 6/20 0.67
POLB P06746 3/20 0.67
NPSR1 Q6W5P4 1/20 0.64
PIK3CG P48736 3/20 0.58
RAB9A P51151 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
RRM1 P23921 1/20 0.57
GCGR P47871 1/20 0.56
GAA P10253 2/20 0.56
MGAM O43451 1/20 0.56
SI P14410 1/20 0.56
MGAM2 Q2M2H8 1/20 0.56
NPC1 O15118 1/20 0.55
HPGD P15428 1/20 0.55
NTRK1 P04629 2/20 0.54
APAF1 O14727 1/20 0.53
ALDH1A1 P00352 1/20 0.53
GFER P55789 1/20 0.52
MAPT P10636 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292666 1.00 MEN1 (0.67) MEN1KMT2APOLBNPSR1PIK3CG
SCHEMBL21292689 0.89 NPSR1 (0.80) MEN1KMT2APOLBNPSR1RRM1
SCHEMBL21292691 0.89 NPSR1 (0.80) MEN1KMT2APOLBNPSR1RRM1
SCHEMBL20299057 0.85 MEN1 (0.75) MEN1KMT2APOLBNPSR1PIK3CG
SCHEMBL20115424 0.85 MEN1 (0.75) MEN1KMT2APOLBNPSR1PIK3CG
SCHEMBL12868832 0.84 DNM1 (0.71) MEN1KMT2APOLBNPSR1PIK3CG
SCHEMBL1129164 0.83 RAB9A (0.78) MEN1KMT2APOLBNPSR1RAB9A
SCHEMBL13791267 0.83 RAB9A (0.78) MEN1KMT2APOLBNPSR1RAB9A
SCHEMBL20115428 0.82 MEN1 (0.63) MEN1KMT2APOLBNPSR1RAB9A
SCHEMBL21292852 0.82 MEN1 (0.63) MEN1KMT2APOLBNPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD MEN1 2502/4885KMT2A 1899/4885POLB 1245/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD MEN1 2502/4885KMT2A 1899/4885POLB 1245/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD MEN1 2502/4885KMT2A 1899/4885POLB 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.